Embryo Incubator Market

Embryo Incubator Market Snapshot (2023 to 2033)

The global embryo incubator market reached a valuation of USD 77.8 million in the year 2022. In 2023, the net worth of all embryo incubators to be sold globally is expected to grow to USD 81.2 million.

FMI forecasts the global market value to reach USD 137.7 million by 2033 while following a CAGR worth 5.4% from 2023 to 2033. Growth of the market is attributed to a rising incidence of in-vitro fertilization techniques amongst patients to facilitate reproduction.

The embryo is the early stage of the formation of a new creature; embryo incubation is particularly essential in the medical business. Embryo transfer is a novel procedure for implanting an embryo into a woman's uterus in preparation for pregnancy. Embryo transfer can be utilized on both animals and humans.

Embryos used for pregnancy can be fresh or frozen for many years; the frozen can be nurtured within incubators for many years under original settings, with appropriate temperature, nutritional medium given to maintain the embryo, adequate humidity, and other elements to support the embryo.

Embryo incubators are highly useful in maintaining the embryo in optimal circumstances, demonstrating that the embryo may be used for continued pregnancy and giving birth to a newborn baby. The female population is having difficulty conceiving owing to numerous internal elements in the body or external causes caused by medical issues.

Embryo incubators benefit the female population seeking IVF (in vitro fertilization). Embryo incubators are available in a variety of models that allow healthcare professionals to monitor the embryo's growth appropriately. A real-time image of the embryo's development is also displayed on a monitor linked to the embryo incubator.

Attribute	Details
Global Embryo Incubator Market Valuation in 2022	USD 77.8 million
Estimated Global Market Share in 2023	USD 81.2 million
Forecasted Global Market Size by 2033	USD 137.7 million
Projected Global Market Growth Rate from 2023 to 2033	5.4% CAGR
Historical Market Growth Rate from 2018 to 2022	3.5% CAGR

Embryo Incubator Demand Analysis (2018 to 2022) Vs. Market Outlook (2023 to 2033)

The global demand for embryo incubators is projected to increase at a CAGR of 5.4% during the forecast period between 2023 and 2033, reaching a total value of USD 137.7 million by 2033. According to a Future Market Insights (FMI) report, from 2018 to 2022, sales witnessed significant growth, registering a CAGR of 3.5%.

The growing need for embryo incubators in cryobanks, reproductive clinics, hospitals, and research facilities throughout the world is driving market growth. This necessity is propelling the industry ahead, resulting in market expansion.

The embryo incubator industry is expected to rise due to increased IVF therapy, increased egg freezing, and more fertility research. As fertility treatments become more popular in South and Central America, the market is predicted to rise in emerging countries such as the Asia Pacific, the Middle East and Africa.

Some Prominent Drivers of the Embryo Incubator Market

Increasing Incidences of Fertility Problems to Drive Market Growth

The market for embryo incubators is expanding as the incidence of fertility problems increases worldwide due to lifestyle disorders. IVF monitoring (in vitro fertilization) assists those who want to start a family with children.

According to the CDC (Centers for Disease Control), around 4 million births occur in the United States each year, with 1 to 2 percent of those births being due to IVF (in vitro fertilization), which directly fuels the market of embryo incubators in the United States.

Another fact that directly fuels the demand for embryo incubators is that 5 million babies worldwide are due to IVF (in vitro fertilization), according to ESHRE (European Society of Human Reproduction and Embryology).

Challenges Faced by the Embryo Incubator Market

High Cost is Likely to Impede Market Growth

The embryo incubator industry is hampered by high prices and a lack of information among healthcare professionals about how to treat embryos in incubators.

Region-wise Insights

North America is an Opportunistic Market for Embryo Incubator Sales

Presence of Leading Market Players Creating Opportunities for Embryo Incubator Manufacturers

Because of the large presence of players in the area and the widespread acceptance of IVF, North America has a significant market share in embryo incubators (in vitro fertilization). North America is expected to lead the market for embryo incubators on a global basis. This is because the general public in North America is becoming more aware of the use of embryo incubators.

The rising market penetration of important firms that provide a variety of embryo incubators is expected to boost the market growth of embryo incubators in the area. Thus, due to the aforementioned reasons, North America possessed 32.4% market share in 2022, registering a CAGR of 4.9% for the embryo incubator market in the assessment period 2023 to 2033

Regional Market Comparison	Global Market Share in Percentage
North America	32.4%
Europe	27.8%

Europe is a Highly Lucrative Market for Embryo Incubator Market Players

Increased Consumer Preference for Utilizing Embryo Incubators favoring Market Growth

As additional competitors enter the region, Europe is the ideal market for the expansion of embryo incubators. The increased consumer preference for utilizing embryo incubators as a result of the development of new technologies is expected to fuel market expansion for the European embryo incubator during the forecast period.

This is projected to be the key driver driving the European embryo incubator market expansion. Thus, Europe held almost 27.8% of the market share in 2022.

Regional Market Comparison	Global Market Share in Percentage
United States	28.7%
Germany	6.8%
Japan	3%

The Outlook of Asia Pacific in the Embryo Incubator Market

Increasing Awareness among Health Professionals Fuelling Rapid Adoption

Asia Pacific is a rising market as healthcare professionals become more aware of the benefits of using an embryo incubator for IVF (in vitro fertilization). Asia Pacific may have significant growth in the next years as a result of an increase in healthcare professionals and fast urbanization, both of which are increasing public awareness of the use of embryo incubators.

The market for embryo incubators is expected to develop due to technological advancements and changes in lifestyle challenges. Thus, Asia Pacific is expected to procure a 10% market share from 2023 to 2033.

Regional Markets	CAGR (2023 to 2033)
United Kingdom	3.8%
China	6.7%
India	5.5%
Australia	4.9%

Category-wise Insights

Fertility Clinics Would Benefit the Most in the Global Embryo Incubator Market

The worldwide market is divided into hospital and research laboratories, fertility clinics, and cryobanks based on end users.

The fertility clinic end-user segment is expected to account for the majority of the global market due to quickly improving technology that has enabled the construction of new fertility clinics.

The numerous fertility clinics provide counseling sessions to couples experiencing infertility issues as a result of bad eating habits and a hectic lifestyle, which leads to ailments such as heart attack, hypertension, diabetes, and so on. Thus, by end user, fertility clinics are expected to record a CAGR of 4.7% in the sales indicator period 2023 to 2033.

Category	By Product Type
Top Segment	Try-gas Incubators
Market Share in Percentage	63.1%

Category	By End User
Top Segment	Fertility Clinics
Market Share in Percentage	42.8%

Start-ups for the Embryo Incubator Market

Many people who seek medical options for infertility experience emotional and physical stress in addition to the financial strain of attempting to conceive.

Seeking help and investigating available choices might be tough in India, where talks about infertility are only sometimes open. On the other hand, these firms guarantee that couples - both men and women - feel comfortable discussing and discovering infertility treatments. Key startup players in the global market are

• In the coming decades, a fast-expanding fertility business and increasing access to IVF procedures may account for almost 300 million worldwide births, virtually all of which may rely on frozen reproductive cells. TMRW's integrated platform offers the world's first RFID cryo-temperature compatible digital chain of custody for all reproductive cells, including eggs and embryos. TMRW software is always on guard, automating 17,000 daily environmental health checks to protect the safety and security of the world's most valuable cells.
• In 2018, Aengus Tran and Dimitry Tran launched Harrison.ai, a clinician-led healthcare artificial intelligence (AI) firm. Their objective is to constantly create and commercialize more efficient and cost-effective healthcare products and services for providers and patients. Harrison.ai provides customized AI-enabled solutions to physicians and healthcare professionals that integrate into existing clinical workflows, resulting in improved patient outcomes.

Harrison.ai, so far, has successfully designed, verified, and implemented a deep learning model (IVY) for forecasting the chance of pregnancy using time-lapse incubation recordings in collaboration with their partner, Virtus Health Limited.

IVY is a patent-pending technology that has enhanced clinical pregnancy success rates in IVF treatment by more than 30% (the success rate of an average embryologist picking a viable embryo is about 65%, but Harrison.ai's IVY has a discriminative power of 93%).

Market Competition

Esco Micro Pte. Ltd., Vitrolife, Genea Biomedx, Cook Medical Inc., Thermo Fisher Scientific Inc., Genea Limited, EMD Sereno Inc. (sub. Merck KGaA), IVFtech ApS, and the Baker Company are among the industry participants.

Recent Key Developments in the Market:

• In May 2022, Cook Medical introduced the MINC+TM Benchtop Incubator for IVF facilities in the United States and Canada.
• In May 2022, Cook Medical has always been dedicated to improving people's lives. This pledge extends beyond patient care to the communities in which the organization works. Cook Medical's Winston-Salem manufacturing plant recently obtained IS0 14001 accreditation, the global environmental management system standards standard.
• In September 2021, as global SARS-CoV-2 research efforts continue, labs increasingly perform scientific investigations utilizing stored saliva samples, taking advantage of a non-invasive sample type. To that aim, Thermo Fisher Scientific has introduced the Thermo Scientific SpeciMAX Stabilized Saliva Collection Kit*, intended to collect saliva securely for research purposes.
• In July 2021, Hamilton Thorne Ltd., a key provider of precision instruments, consumables, software, and services to the ART research and cell biology sectors, announced that it had completed the purchase of IVFTECH ApS (IVFtech) and its connected reseller arm, K4 Technology ApS. (K4).

Report Scope

Attribute	Details
Market Value in 2023	USD 81.2 million
Market Value in 2033	USD 137.7 million
Growth Rate	CAGR of 5.4% from 2023 to 2033
Base Year for Estimation	2022
Historical Data	2018 to 2022
Forecast Period	2023 to 2033
Quantitative Units	Revenue in USD million and CAGR from 2023 to 2033
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered	Product Type, End User, Region
Regions Covered	North America;  Latin America;  Europe;  Asia Pacific;  The Middle East and Africa
Key Countries Profiled	United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Italy, China, Japan, South Korea, India, Malaysia, Singapore, Australia, New Zealand, GCC, South Africa, Israel
Key Companies Profiled	Esco Micro Pte. Ltd.; Vitrolife; Genea Biomedx; Cook Medical Inc.; Thermo Fisher Scientific Inc.; Genea Limited; EMD Sereno Inc.; IVFtech ApS; The Baker Company
Customization	Available Upon Request

Key Segments Profiled in the Embryo Incubator Industry Survey

By Product Type:

• Tri-gas Incubators
• Tri-gas Incubators with Camera

By End User:

• Hospital and Research Laboratories
• Fertility Clinics
• Cryobank

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• The Middle East and Africa

Frequently Asked Questions

What is the Market Valuation in 2023?

The market is expected to be valued USD 81.2 million in 2023.

How Much will the Market be Worth in 2033?

The market is anticipated to be worth USD 137.7 million by 2033.

What was the HCAGR of the Market's Growth?

Sales on the market developed between 2018 and 2022 at an HCAGR of 3.5%.

What is the Anticipated CAGR for the market?

Through 2033, the market is going to develop at a 5.4% CAGR.

What Category of Product Type is Considered Influential?

The Try-gas Incubators category to acquire a market share of 63.1%.

What is the Share for the United States Market?

The United States market to grab a share of 28.7%through 2033.

What is the Growth Outlook for China Market?

China market is predicted to garner a CAGR of 6.7%.